Earnings Summary

Opko Health, Inc.’s revenue fell -0.64% since last year same period to $178.6Mn in the Q3 2023. On a quarterly growth basis, Opko Health, Inc. has generated -32.71% fall in its revenue since last 3-months.

Opko Health, Inc.’s net profit jumped 1.8% since last year same period to $-84.5Mn in the Q3 2023. On a quarterly growth basis, Opko Health, Inc. has generated -330.24% fall in its net profits since last 3-months.

Opko Health, Inc.’s net profit margin jumped 1.17% since last year same period to -47.31% in the Q3 2023. On a quarterly growth basis, Opko Health, Inc. has generated -539.39% fall in its net profit margins since last 3-months.

Opko Health, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a 0% jump from last quarter’s estimates.

Opko Health, Inc.’s earning per share (EPS) estimates for the current year stand at -0.1.

Opko Health, Inc.’s earning per share (EPS) jumped 0% since last year same period to -0.11 in the Q3 2023. This indicates that the Opko Health, Inc. has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Opko Health, Inc.’s return on assets (ROA) stands at -0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Opko Health, Inc.’s return on equity (ROE) stands at -0.14.